About Prof. David Williams

Prof-David-WilliamsProfessor Williams, age 69, is one of the world’s leading authorities on biomaterials and implantable medical devices, with 40 years experience in the academic, governmental, legal and industrial aspects of this business. He was at the University of Liverpool, UK, until the end of 2007 where he established one of the world’s first bio-materials research laboratories in 1967 and, over the following years a Department of Clinical Engineering.

Between 1997 and 2001 he was Pro-Vice-Chancellor of the University and in 2001 became Director of the UK Centre for Tissue Engineering. Professor Williams was trained as a metallurgist, obtaining a First Class Honours Degree, a Ph.D. and a D.Sc, all at the University of Birmingham, UK. He is a Fellow of the American Institute of Medical and Biological Engineering and a Founding Fellow of Biomaterials Science and Engineering of the International Societies of Biomaterials. He has received awards from the main biomaterials societies in the USA, UK, Europe and India. In 2007 he received the highest award of the US Society for Biomaterials and also of the UK Institute of Materials (The Chapman Medal). In 2001 he was elected to the Fellowship of the Royal Academy of Engineering. He has published close to 400 scientific papers and written or edited 35 books. On leaving the University of Liverpool in 2007, he was given the title of Emeritus Professor and is now partner in a consulting company, Morgan & Masterson in Brussels. He also took up the position of Director of International Affairs at the Wake Forest Institute of Regenerative Medicine, North Carolina, USA and Visiting Professor at universities in Beijing, and Shanghai in China, and at the University of New South Wales, Australia, as well as in the University of Cape Town. He is Editor-in-Chief of Biomaterials, the world’s leading journal in its field.

During the last 40 years Professor Williams has consulted to most global medical device companies and has been on Scientific Advisory Boards of many companies. At one time he was Director of AorTech International based in Scotland, UK and its Australian subsidiary Elastomedic Pty. In the latter capacity he was responsible for development work on a biostable polyurethane and a radically new polymeric heart valve. Professor Williams has also been extensively used as a consultant in product liability and patent litigation, providing valuable international expertise and insight into this important area of the medical device industry, which will be of great strategic use to SAT.

More about the founders